Molnupiravir 200 mg

Molnupiravir 200 mg is an oral antiviral medication used for the treatment of mild to moderate COVID-19 in adults who are at high risk of developing severe illness. It works by introducing errors into the virus’s genetic material, which prevents the virus from multiplying effectively within the body.

Molnupiravir is typically recommended for patients within five days of symptom onset, helping to reduce the risk of hospitalization and complications associated with COVID-19.

Key Benefits:

• Reduces severity and progression of COVID-19

• Easy-to-administer oral capsule

• Effective against early-stage SARS-CoV-2 infection

• Suitable for high-risk adult patients

Usage Instructions:
Take Molnupiravir 200 mg exactly as prescribed, usually four capsules per day (total 800 mg), every 12 hours for 5 days. Do not skip doses and do not take more than the recommended amount.

Precautions:

• Not recommended during pregnancy or breastfeeding

• Not approved for use in children under 18

• Should not be used as a substitute for vaccination

• Always consult a doctor before starting treatment

Common Side Effects:

• Headache

• Diarrhea

• Nausea

• Dizziness

• Mild allergic reactions (in rare cases)